Clinical Research Facility

Baldwin Park, California 91706

We've found

2 trials

at this facility

Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Baldwin Park, CA

Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

Status: Enrolling
Updated: 11/29/2016

from

Baldwin Park, CA

Use our guide to learn which trials are right for you!